Smart Pharma Soft Solutions Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -29.08%
- Profit Growth -46.84%
- Ebitda -22.11%
- Net Worth 1.63%
- Total Assets 130.20%
About Smart Pharma Soft Solutions
Smart Pharma Soft Solutions Private Limited (SPSSPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 02 May 2019 (Five years and nine months 26 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Software Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ramamohan Kethireddy and Jhansirani Kethireddy serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U72200TG2019PTC132468
- Company No.
132468
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 May 2019
- Date of AGM
23 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Smart Pharma Soft Solutions?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramamohan Kethireddy  | Director | 02-May-2019 | Current |
| Jhansirani Kethireddy | Director | 11-Feb-2021 | Current |
Financial Performance of Smart Pharma Soft Solutions.
Smart Pharma Soft Solutions Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 29.08% decrease. The company also saw a substantial fall in profitability, with a 46.84% decrease in profit. The company's net worth moved up by a moderate rise of 1.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Smart Pharma Soft Solutions?
Unlock access to Smart Pharma Soft Solutions's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Smart Pharma Soft Solutions?
Unlock and access historical data on people associated with Smart Pharma Soft Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Smart Pharma Soft Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Smart Pharma Soft Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
